Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients-Reference-Cited by-同舟云学术

Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patients

Published:2020-07-08 Issue:9 Volume:20 Page:2567-2570
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Levy Clementine¹²^ORCID,Lassailly Guillaume¹²,El Amrani Mehdi³,Vincent Flavien⁴,Delhaye Cedric⁴,Meurice Thibault⁵,Boleslawski Emmanuel³,Millet Guillaume³,Ningarhari Massih¹²,Truant Stephanie³,Louvet Alexandre¹²,Mathurin Philippe¹²,Lebuffe Gilles⁶,Pruvot François‐René³,Dharancy Sébastien¹²

Affiliation:

1. Department of Hepatogastroenterology CHU Lille Lille France

2. INSERM U995University of Lille Lille France

3. CHU Lille Department of Digestive Surgery and Transplantation University of Lille Lille France

4. Cardiology CHU LilleInstitut Coeur PoumonUniversity of Lille Lille France

5. Cardiology Hôpital Privé Le Bois Lille France

6. CHU Lille Department of Anesthesiology, Resuscitation, and Critical Care Anesthesiology University of Lille Lille France

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link